Additional studies are also necessary to verify whether adding resistin to previously validated tools38, 39 improves the ability to predict mortality rate in T2D and to explore if treatments aimed at reducing resistin levels36, 40, 41 also decrease the risk of death in such patients. Here, RETN is linked to type 2 diabetes mellitus.